BioLife Solutions, Inc. Deferred Revenue, Revenue Recognized
BioLife Solutions, Inc. (BLFS) reported Deferred Revenue, Revenue Recognized of $242.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2023-05-11
- BioLife Solutions, Inc. deferred revenue, revenue recognized for the quarter ending 2023-03-31 was $242.00K, a 227.03% increase year-over-year.
- BioLife Solutions, Inc. deferred revenue, revenue recognized for the quarter ending 2022-09-30 was $26.00K.
- BioLife Solutions, Inc. deferred revenue, revenue recognized for the quarter ending 2022-06-30 was $382.00K.
- BioLife Solutions, Inc. deferred revenue, revenue recognized for the quarter ending 2022-03-31 was $74.00K.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month |
|---|---|---|---|
| 2023-03-31 | $242.00K 10-Q · filed 2023-05-11 | ||
| 2022-09-30 | $26.00K 10-Q · filed 2022-11-09 | $482.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $382.00K 10-Q · filed 2022-08-09 | $456.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $74.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |